Murtaza, G., Turagam, M.k., Garg, J., Boda, U., Akella, K., Velagapudi, P., et al. (2021). Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease. INDIAN PACING AND ELECTROPHYSIOLOGY JOURNAL, 21(4), 221-226 [10.1016/j.ipej.2021.04.002].

Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease

Natale A.
;
2021-01-01

2021
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MEDS-07/B - Malattie dell'apparato cardiovascolare
English
Murtaza, G., Turagam, M.k., Garg, J., Boda, U., Akella, K., Velagapudi, P., et al. (2021). Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease. INDIAN PACING AND ELECTROPHYSIOLOGY JOURNAL, 21(4), 221-226 [10.1016/j.ipej.2021.04.002].
Murtaza, G; Turagam, Mk; Garg, J; Boda, U; Akella, K; Velagapudi, P; Natale, A; Gopinathannair, R; Lakkireddy, D
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/416829
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact